Release Date: 19/01/09 10:38 Summary: Everest Financial Group confirms name change Price Sensitive: No Download Document 27.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%